There is still a place for tumour-targeted therapies in Merkel cell carcinoma in the era of immune checkpoint inhibitors

被引：4
|
作者：
Samimi, M. [1 ,2 ]
Becker, J. [3 ,4 ]
机构：
[1] Univ Tours, Dermatol Dept, Tours, France
[2] Univ Tours, Lab Biol Infect Polyomavirus, INRA, ISP1282, Tours, France
[3] German Canc Consortium DKTK, Translat Skin Canc Res, Essen, Germany
[4] Univ Med Essen, Essen & Deutsch Krebsforschungszenrtrum DKFZ, Essen, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 02期
关键词：
D O I：
10.1111/bjd.19247
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [31] Current statuses of molecular targeted and immune checkpoint therapies in hepatocellular carcinoma
    Kong, Deqiang
    Liu, Chen
    Miao, Xiaolong
    Wang, Yao
    Ding, Xianfeng
    Gong, Weihua
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (05): : 1522 - 1533
  • [32] The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
    Kim, Beom Kyung
    GUT AND LIVER, 2024, 18 (01) : 3 - 4
  • [33] Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?
    Hauschild, Axel
    Schadendorf, Dirk
    LANCET ONCOLOGY, 2016, 17 (10): : 1337 - 1339
  • [34] Successful Reinduction with Immune Checkpoint Inhibitor in Metastatic Merkel Cell Carcinoma
    Bradfisch, F.
    Stege, H.
    Henning, B.
    Mitzel-Rink, H.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 21 - 22
  • [35] Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors
    Shapiro, Daniel D.
    Abel, E. Jason
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 513 - 520
  • [36] Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors
    Vigarios, Emmanuelle
    Epstein, Joel B.
    Sibaud, Vincent
    SUPPORTIVE CARE IN CANCER, 2017, 25 (05) : 1713 - 1739
  • [37] New Developments in the Treatment of Metastatic Melanoma: Immune Checkpoint Inhibitors and Targeted Therapies
    Azijli, Kaamar
    Stelloo, Ellen
    Peters, Godefridus J.
    Van den Eertwegh, Alfons J. M.
    ANTICANCER RESEARCH, 2014, 34 (04) : 1493 - 1505
  • [38] Indirect comparison between immune checkpoint inhibitors and targeted therapies for the treatment of melanoma
    Wu, Minliang
    Wang, Yuchong
    Xu, Yalong
    Zhu, Ji
    Lv, Chuan
    Sun, Mengyan
    Guo, Rui
    Xia, Yu
    Zhang, Wei
    Xue, Chunyu
    JOURNAL OF CANCER, 2019, 10 (24): : 6114 - 6123
  • [39] Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors
    Emmanuelle Vigarios
    Joel B. Epstein
    Vincent Sibaud
    Supportive Care in Cancer, 2017, 25 : 1713 - 1739
  • [40] Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies
    Ouyang, Tao
    Kan, Xuefeng
    Zheng, Chuansheng
    FRONTIERS IN ONCOLOGY, 2022, 12
12345